Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000004

Chief Medical Officer sold 1,789 shares at $22.99 ($41,129)

  • Chief Medical Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 29,658 D
2024-01-09 Sale : show line 2 in the form 10b5-1 −1,789 $22.99 $41,129 27,869 D
Open-market sales · 1,789 sh · avg $22.99 · $41,129

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-05 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −5,000 0 D
Loading xslF345X05/wk-form4_1704835314.xml…